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Summary
Duchenne and Becker muscular dystrophies are among the most severe and frequent inherited
disorders. Being still incurable, medical treatment is concentrated on the carrier diagnosis of the
members of the affected families. Here we report the results of the studies of 151 members of 41
Hungarian families, obtained with multiplex PCR amplification of 18 exons as well as the muscle
specific promoter region, and haplotype analysis of two polymorphic (CA)
n
repeat microsatellite loci
in introns 45 and 49 of the dystrophin gene. The analysis of 15 deletion-type families revealed a
frequency of new mutations not differing significantly from that in the other regions of Europe. We
also compared the allele distributions of the two microsatellites in randomly selected normal
individuals and affected family members. The allele distribution of STRP45 shows interesting
differences between the two populations.
introduction
Duchenne}Becker muscular dystrophies
(D}BMD) are amongst the most common and
severe X-linked disorders, with an incidence of
approximately 1 in 3500 new-born males
(Roberts, 1995). In most cases deletions in the
dystrophin gene have been shown (den Dunnen
et al. 1987; Hu et al. 1990). Due to the giant size
of the gene, new mutations were reported in one
third of the patients from different populations
(Roberts, 1995). The determination of carriers is
an important aspect in providing prenatal di-
agnosis and genetic counselling to families with
D}BMD patients. The detection of carrier status
of at-risk family members is problematic how-
ever, because of the insufficient number of
informative markers. The methods are usually
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based on haplotype or dosage analysis of poly-
morphic markers, or short tandem repeat poly-
morphisms (STRPs), Southern blots or quan-
titative PCR (Mao & Cremer, 1989; Hu et al.
1990; Clemens et al. 1991).
Here we report the analysis of family members
of Hungarian D}BMD patients. The original
molecular diagnosis of the patients was made by
multiplex PCR (Beggs et al. 1990; Chamberlain
et al. 1990). The analysis of the carrier status of
the individuals was carried out using two short
tandem repeat polymorphic markers within
introns 45 and 49 of the dystrophin gene
(Clemens et al. 1991). The loss of heterozygosity
of these markers indicates carrier status. Since
microsatellite analysis has been successfully used
to compare genetic diversity among populations
(Brinkmann et al. 1998), we have also investi-
gated if these STRP markers exhibit any
population-specific characteristics.
512 C. Z. Bachrati and others
This is the first attempt to estimate the rate of
new mutations in D}BMD in this part of Europe.
This is particularly relevant, since the region’s
environment is considered to be more contami-
nated than other parts of Europe, and therefore
a higher than ‘normal’ mutation rate would be
expected.
materials and methods
Patients and controls
The diagnosis of our DMD and BMD patients
was based on the clinical symptoms, the highly
elevated serum creatine phosphokinase (CPK)
values, myopathic changes in electromyography
and on muscle biopsy. Blood samples from 50
unrelated, randomly chosen new-born children
were used as controls.
Isolation of genomic DNA from peripheral blood
Blood samples were collected from the patients
and family members on the basis of informed
consent. DNA was prepared from leukocyte
nuclei with slight modifications of the method
described by Woodhead et al. (1986). Briefly,
4 ml peripheral blood was anticoagulated with
1 ml of 5% EDTA and haemolysed by freeze-
thawing. White blood cells were lysed with the
addition of 45 ml lysis buffer (0–32 M sucrose,
5 mm MgCl
#
, 10 mm TRIS-HCl pH: 7–4, 1%
Triton-X100). Nuclei were pelleted by centri-
fugation, washed in PBS twice and resuspended
in 1 ml solution of 75 mm NaCl, 50 mm EDTA.
Nuclei were lysed and digested with the addition
of 100 ll 10% SDS and 22 ll 25 mg ml−" Pro-
teinase K (Merck) (1% and 0–5 mg ml−" final,
respectively) overnight at 55 °C. DNA was
phenol extracted, precipitated with ethanol, and
dissolved in TE.
Multiplex PCR
For the detection of deletions in the dystrophin
gene, the multiplex PCR methods described by
Beggs et al. (1990) and Chamberlain et al. (1990)
were used.
Detection of STRPs
The oligonucleotide primers used for PCR
amplification of STRP45 (DMD-45}A and DMD-
45}B) and STRP49 (DMD-49}A and DMD-
49}B) were described by Clemens et al. (1991).
Primers for the internal amplification control
CFTR8 were the following: CFTR8F: 5«-
TCTATCTCATGTTAATGCTG-3« ; CFTR8R: 5«-
GTTTCTAGAGGACATGATC-3«. The amplifi-
cation was carried out in 50 ll total volumes,
containing 80 ng genomic DNA, 10 pmol each of
forward and reverse primers for the STRP45 or
STRP49, and 20 pmol of each primer for the
CFTR8 STRP, 200 lm R dNTP, 10 mm Tris-HCl,
pH:8–5, 50 mm KCl, 1–5 mm MgCl
#
, 0–3 lCi $#P[a-
dCTP] and 3U Taq polymerase. The amplifi-
cation was carried out in the following cycles :
94 °C, 4 min! 53 °C, 45 sec! 72 °C, 30 s: 1‹ ;
94 °C, 30 s! 53 °C, 45 s! 72 °C, 30 s: 26‹ ;
94 °C, 30 s! 53 °C, 45 s! 72 °C, 4 min: 1‹ ;
4 °C. 2–5 ll product was mixed with equal
amount of sequencing dye, denatured at 80 °C
for 2 min, run on 6% denaturing polyacrylamide
sequencing gel and autoradiographed. The sizes
of alleles were determined by comparison with
control sequencing reactions of plasmids with
known sequences, electrophoresed on the same
gel.
Statistical analysis
Sum of Gaussian curves was fitted to the
observed data with robust method according to
the equation:
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where m and s are the mean and standard
deviation values, k}s is the height and i is the
number of the peaks. The goodness of fit was
assessed by the Kolmogorov–Smirnov goodness
of fit method (Zar 1984).
results and discussion
In the studies presented here, 151 members of
41 families with one or more D}BMD patients
were involved. Based on clinical and diagnostic
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Fig. 1. Flowchart summarising the distribution of the individuals included in this study, and the results of
the multiplex PCR analysis. Due to the earlier death of five patients they were not involved in the multiplex
PCR analysis, the genetic counselling of their family members based on STRP analysis.
symptoms, out of 51 patients, 48 showed
Duchenne and 3 showed Becker allelic forms of
the disease. We also had two symptomatic female
carriers, in one family the mother, in another
family the sister of the DMD patient showed the
symptoms. This finding is well known in the
literature (Kowalewski et al. 1966; Barkhaus &
Gilchrist, 1989; Shigihara-Yasuda et al. 1992).
Multiplex PCR analysis
In order to detect gene deletions, 19 intragenic
regions, spanning 18 exons as well as the muscle
specific promoter, were amplified in multiplex
PCR reactions. Forty-four D}BMD patients and
five chorion biopsy samples from male foetuses
were involved in the multiplex PCR studies (Fig.
1). In three chorion biopsy samples it was
possible to rule out the disease. In two cases from
one family the foetus proved to be affected, and
on the genetic counselling the parents decided to
abort the pregnancies (mother D}303 in Fig. 6).
Thirty-one out of 46 affected patients (67–4%)
showed deletions, while 15 showed no deletions
in the regions studied. The distribution of the
exon deletions (Fig. 2) is in good agreement with
the studies published by others (Roberts, 1995),
with most deletions falling into the 3« deletion
hot spot region, between exons 45 and 52.
STRP analysis
Out of the 151 family members, 138 were
involved in the STRP studies. In 78 cases both
STRPs (in intron 45 and 49, respectively) were
analysed, while in 60 cases only the STRP in
intron 45 was used. Both STRPs were used in
families, where deletion of either marker was
expected. Results of the STRP analysis are
summarised in Fig. 3.
The data obtained from 34 family members of
13 families did not result in informative poly-
morphic profile; mutations causing the
dystrophic phenotype fell out of the region
studied. As it has already been reported, STRP
analysis can provide suitable information for
carrier detection in the absence of DNA from an
affected boy (Richards et al. 1992). Similarly, we
tried to trace back the mutations in five patients
of three families from the STRP profile of the
relatives (they were not involved in the multiplex
PCR analysis either, see Fig. 1). Neither STRP
markers were found to be deleted in the relatives,
presumably, because the mutation did not hit
these regions. The STRP profiles, therefore,
proved to be non-informative; no reliable genetic
advice could be given to the families.
The analysis was informative in 28 families,
providing useful STRP profiles for either estab-
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Fig. 2. Frequency of deletions in the 19 studied regions of the DMD gene in Hungarian families. Pm:
muscle specific promoter, e3-e60: exons.
Fig. 3. Flowchart summarising the distribution of families analysed with STRP45 and STRP49. A family
is considered to be informative if either the carrier state of the mother can be proven, or the potential carrier
status of sisters of either the mother or the affected patient can be determined.
lishing the origin of the mutation, or tracing
potential carriers in the affected families.
Twenty-one probands of 15 families had
deletion-type mutations that affected either or
both STRPs. In nine families the affected 15
patients inherited the mutation from their
mothers who were themselves carriers (10 carrier
mothers), while in six families (6 patients) the
mother proved to be non-carrier having new
mutation. Thus, the new mutation rate is 37–5%
(6 new mutation out of 16 mothers). This figure,
though the number of patients is not high, is not
very much different from the one third ratio of
new mutations observed in other geographical
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Fig. 4. Pedigree of a DMD family with mutation originated from the grandmother. The two affected males
showed deletions between e45 and e52, that also affected the two STRP markers. Mother D}297, as well as
chorion biopsy D}294 showed loss of heterozygosity of the two STRP markers. In the case of grandmother
D}314, STRP analysis indicated intact chromosomes, therefore this grandmother must be the origin of a
new mutation. The numbers below the symbols of each family members indicate PCR fragment sizes as
alleles ; upper number: STRP45, lower number: STRP49, D : deletion.
regions (Roberts, 1995), except for data from
Northern Indian patients where higher frequency
of new mutations was reported (Sinha et al.
1996).
In a few families it was possible to determine
the origin of the mutation of the mother, because
the grandparents of the probands were alive and
their DNA could be analysed. As an example, the
family tree in Fig. 4 shows a mutation that was
developed in the maternal grandmother resulting
in a carrier mother. The sister of the carrier
mother does not show the deletion haplotype.
The pedigree in Fig. 5 shows a different
mutational origin. Though DNA samples from
the maternal grandparents were not available,
the haplotype of the grandparents can be traced
back based on the STRP profile of the carrier
mothers. The origin of the mutation therefore
can be explained with the asymptomatic carrier
state or germline mosaicism of the grandfather;
both cases have already been reported by others
(Hennekam et al. 1989; Claustres et al. 1990).
However, the trivial possibility of non-paternity
can also be a plausible explanation.
The family tree in Fig. 6 shows a typical
familial inheritance. Mother D}303 sought gen-
etic counselling having had a deletion type
brother, as were shown with multiplex PCR
analysis. Her first two pregnancies resulted in
two boy foetuses with the same multiplex PCR
deletion pattern. She requested to abort both
pregnancies. Third time her foetus proved to be
a carrier daughter, whom she delivered suc-
cessfully. Her sister also sought genetic advice
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Fig. 5. Pedigree of a DMD family with the grandfather as proposed mutational origin. Multiplex PCR
analysis indicated deletions between e45 and e50 in all three affected males, while chorion biopsy D}251
showed no deletions, proved to be healthy. Mothers D}127 and D}144 are hemizygous, therefore carriers,
for the two STRP markers. Haplotype of the grandmother can be traced back from that of the mothers (thin
faced numbers), in this case the origin of the mutation must be the grandfather.
during her pregnancy. In this case chorion biopsy
showed a full trisomic chromosome set, that was
further supported by the STRP analysis. This
pregnancy ended with spontaneous abortion.
With the STRP analysis later, the non-carrier
status of this sister, and the carrier state of the
grandmother were shown.
In 13 families the STRP markers studied were
not hit by deletion event, therefore it was not
possible to show where the mutation occurred.
However, based on STRP profiles five sisters of
seven families proved to be unlikely carriers,
because their STRP haplotypes were different
from that of the affected brothers. In this family
group we made four prenatal diagnoses that
resulted in two healthy boys, a non-carrier
daughter, and a non-informative haplotype.
Interestingly, in two families the haplotypes of
the family members (carrier mothers and ma-
ternal grandmothers) showed that the chromo-
somes with the haplotypes linked to the disease
must have come from the maternal grandfathers.
Unfortunately, due to the lack of DNA samples
from the grandfathers no further investigation
was possible. In the other family group (6
families), seven sisters showed the same haplo-
type as the affected patients, therefore they were
considered being at-risk carriers.
In two cases, the multiple PCR and STRP
analyses provided contradictory results. One
patient showed deletions of e45, e47, e48, e49 and
e50. Contrary to this, amplification of the STR in
intron 45 (STRP45) was successful, STRP49 was
deleted. Similarly, another patient showed
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Fig. 6. A typical family tree showing inheritance of the disease through generations. The affected male, D}96
had a deletion type mutation between e47 and e52. Chorion biopsies D}186 and D}279 showed the same
deletion pattern. Haplotype analysis revealed carrier status of D}302 and D}303, as well as chorion biopsy
D}300. This family was also hit by the spontaneous abortion of D}201 who was trisomic for the full
chromosome set. Thin-faced numbers indicate proposed STR haplotypes.
deletions of e49, e50, e51 and e52, while amplifi-
cation of the STR in intron 49 (STRP49)
succeeded. Both cases can only be explained with
double recombination in the affected regions,
which has also been reported by others (Morrone
et al. 1997).
Distribution of STRP alleles in Hungarian
populations
Since we had a relatively high number of
families with D}BMD, it seemed appropriate to
analyse the pattern of distribution of the poly-
morphisms in introns 45 and 49 and compare
with those of healthy, randomly selected
controls. Figure 7 shows the allele distributions
of STRP45 originated from the analysis of 201
chromosomes from members of families with
D}BMD patients, compared with those of 58
chromosomes of randomly selected Hungarian,
and 57 chromosomes of American Caucasian
healthy individuals (Clemens et al. 1991). There
is a biphasic distribution with a smaller peak at
158 bp and a characteristic second peak at 174 bp
in healthy Hungarian individuals, while in the
case of members of families with muscular
dystrophy probands this second peak is at
172 bp. The second peak is accompanied by a
shoulder at 166 in the affected group, while this
shoulder is at 168 bp in the control group. The
distribution of the control group is also different
from that published for the American Caucasian
population, where the second peak is at 172 bp,
the shoulder is at 168 bp.
These direct observations were also confirmed
by statistical analysis. Three component normal
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Fig. 7. Comparison of STRP45 allele distributions among members of families with D}BMD patients,
randomly selected Hungarian and American Caucasian healthy individuals (Clemens et al. 1991). In the
164–178 bp range the distribution pattern of the affected family members shows a one-repeat shift towards
the lower repeat number categories compared to the healthy Hungarian controls. Interestingly, the most
frequent allele is 172 bp in the North-American population, similarly to the Hungarian affected family
members. A secondary peak at 158 bp can be observed in all of the three different populations.
Fig. 8. Distribution of CFTR8 alleles in randomly selected normal controls and individuals of families
affected with D}BMD. The most frequent alleles are 200 and 202 bp long in both the affected and the
randomly selected normal populations. However, the one-repeat shorter allele seems to be preferred in the
affected family members, similarly to the one-repeat shorter STRP45.
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Fig. 9. Distribution of STRP49 alleles of members of families affected with D}BMD, randomly selected
Hungarian and American Caucasian healthy individuals (Clemens et al. 1991). Unlike in the case of STRP45,
the sizes of the amplified STRP49 fragments are distributed more-or-less evenly, and randomly. No
characteristic differences between the allele distribution of the affected and normal control individuals can
be observed. The allele distribution of the Hungarian and North-American control populations do not differ
significantly either.
distribution curves were fitted to the observed
data (not shown). According to Kolmogorov–
Smirnov goodness of fit analysis the fitted curves
were in very good agreement with the observed
values (0–5!p). The hypotheses, if the fitted
allele distributions are the same, were tested
with the Kolmogorov–Smirnov goodness of fit
method. Probability values show that the allele
distributions of the healthy and affected group
differ significantly (0–002!p! 0–005), as well as
the Hungarian and American Caucasian healthy
control groups (0–01!p! 0–02), while there is
no significant difference between the allele distri-
butions of the affected Hungarian and healthy
American Caucasian control groups (0–5!p).
In order to prove that smaller repeat number
polymorphisms could really be connected to
D}BMD more data are needed. Interestingly, the
STRP profile in intron 8 of the CFTR gene
(which was used throughout this study as an
internal control for successful amplification)
shows preference of the shorter (200 bp) versus
the longer (202 bp) most frequent alleles in the
272 chromosomes of the at-risk family members,
while such a preference does not exist among the
74 chromosomes of the controls (Fig. 8). One
component Gaussian distribution curves were
fitted to the values of both sets of data. Though
the Kolmogorov–Smirnov goodness of fit test
showed low accuracy of the fits (0–005!p! 0–01
for the normal control, and 0–005!p! 0–01 for
the affected family members) better fit could not
be achieved. However, the test, if the two allele
distributions are the same showed significant
difference (P! 0–001 with both the observed and
fitted distributions).
Preference of shorter alleles cannot be
recognised in the case of STRP49. As depicted in
Fig. 9, it would be very hard to fit a relatively
simple distribution curve to any group of data
that would support this conclusion.
In the study presented here, we summarised
the results of the carrier detection and prenatal
diagnosis of 41 families with 151 individuals. The
environment of this part of Europe is considered
to be more contaminated than other parts of the
continent, therefore one would have expected
higher frequency of new mutations and higher
520 C. Z. Bachrati and others
incidence of the disease. Our data support neither
expectations, moreover, the cases that appeared
to be extraordinary at first sight have already
been reported by others as well. The very
interesting finding is, however, that in families
affected by D}BMD, in at least two loci, one
repeat shorter microsatellites occur at a higher
frequency than in the normal control individuals.
The significance of this finding remains to be
elucidated.
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